This list is an analysis based on recent market events. It's not an investment recommendation.
About
KAINOS Laboratories, Inc. develops, manufactures, markets, distributes, and imports/exports pharmaceuticals, diagnostic reagents, related chemical products, physical and chemical measurement instruments, medical supplies, nutrition supplements, foodstuff, animal feed, and related products in Japan. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-III plus Test Kit for automatic analyzer systems; Aqua-auto Kainos ALB Test Kit, a liquid form reagent kit; and Aqua-auto Kainos UN-II Test Kit, a liquid urea nitrogen measurement reagent kit. It also provides FGF-23 ELISA Kit, a two-site enzyme-linked immunosorbent assay kit for the measurement of FGF-23 in serum; Swiftgene Norovirus GI/GII Kainos for detecting noroviruses; Statmark FLUstick II for use in detecting type a and type b influenza virus antigens; and Statmark Strep A for detecting Group A beta-hemolytic streptococci. The company was formerly known as DOMS-IATRON Co., Ltd. and changed its name to KAINOS Laboratories, Inc. in July 1975. KAINOS Laboratories, Inc. was founded in 1975 and is headquartered in Tokyo, Japan.
The current price of 4556.TSE is ¥2,266 JPY — it has decreased by -0.35% in the past 24 hours. Watch Kainos Laboratories stock price performance more closely on the chart.
What is Kainos Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kainos Laboratories stocks are traded under the ticker 4556.TSE.
What is Kainos Laboratories market cap?▼
Today Kainos Laboratories has the market capitalization of 10.33B
When is the next Kainos Laboratories earnings date?▼
Kainos Laboratories is going to release the next earnings report on May 08, 2026.
What were Kainos Laboratories earnings last quarter?▼
4556.TSE earnings for the last quarter are 103.1 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Kainos Laboratories revenue for the last year?▼
Kainos Laboratories revenue for the last year amounts to 6.97B JPY.
What is Kainos Laboratories net income for the last year?▼
4556.TSE net income for the last year is 753.04M JPY.
Does Kainos Laboratories pay dividends?▼
Yes, 4556.TSE dividends are paid semi-annual. The last dividend per share was 3 JPY. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Kainos Laboratories have?▼
As of April 16, 2026, the company has 133 employees.
In which sector is Kainos Laboratories located?▼
Kainos Laboratories operates in the Health & Wellness sector.
When did Kainos Laboratories complete a stock split?▼
Kainos Laboratories has not had any recent stock splits.
Where is Kainos Laboratories headquartered?▼
Kainos Laboratories is headquartered in Tokyo, Japan.